AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Daoride-M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Azine Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Daoride-M 2mg/500mg Tablet ER

Metformin/Dapagliflozin extended-release tablets (2mg/500mg) are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue taking this medication even with controlled blood sugar; discontinuation without medical supervision risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan that includes dietary adjustments, exercise, and weight management as directed by your doctor. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a potential consequence for some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting this medication. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.

Primary Ingredients of Daoride-M 2mg/500mg Tablet ER

No text was provided to rewrite.

Uses of Daoride-M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Daoride-M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Daoride-M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Daoride-M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Daoride-M 2mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consumption of the Daoride-M 2mg/500mg Extended-Release tablet should coincide with meals.

How Daoride-M 2mg/500mg Tablet ER works:

Daoride-M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Daoride-M 2mg/500mg extended-release tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Daoride-M tablets (2mg/500mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Daoride-M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose level is abnormally low or elevated. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Daoride-M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Daoride-M 2mg/500mg Extended-Release tablets are contraindicated in those with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

The extended-release Daoride-M 2mg/500mg tablet requires careful administration for individuals with hepatic impairment. Dosage modification of Daoride-M 2mg/500mg extended-release tablets may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Daoride-M 2mg/500mg extended-release tablets are typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Daoride-M 2mg/500mg Tablet ER :

Should you forget to take your Daoride-M 2mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Daoride-M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Daoride-M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Daoride-M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Daoride-M, if these symptoms occur.
Daoride-M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Daoride-M is not suitable for type 1 diabetes.
Daoride-M 2mg/500mg ER Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Daoride-M 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Daoride-M 2mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Daoride-M 2mg/500mg ER tablets with alcohol is unsafe. Alcohol may exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Daoride-M 2mg/500mg Table...
44
MRP 51
13% off